Hostname: page-component-586b7cd67f-r5fsc Total loading time: 0 Render date: 2024-11-23T22:42:21.505Z Has data issue: false hasContentIssue false
  • English
  • Français

Effect of Shape of Medication in Treatment of Anxiety States

Published online by Cambridge University Press:  29 January 2018

M. Z. Hussain
M. Z. Hussain*
Affiliation:
Victoria Union Hospital, 1200 24th Street West, Prince Albert, Saskatchewan, Canada
Get access Rights & Permissions [Opens in a new window]

Extract

In the clinical evaluation of drug treatment, medical practitioners have long appreciated the fact that the response does not merely reflect the pharmacological effect of the drug. The manner in which the treatment is presented to the patient by his therapist is important and there is ample proof in the literature of the therapeutic effects of inert substances—the so-called placebo effects (1, 2). In psychiatric practice particularly, the halo effects of such factors are of considerable importance.

Type
Research Article
Information
The British Journal of Psychiatry , Volume 120 , Issue 558 , May 1972 , pp. 507 - 509
Copyright
Copyright © Royal College of Psychiatrists, 1972 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Beecher, H. K. (1955). ‘The powerful placebo,’ Journal of the American Medical Association, 159, 1602–6.CrossRefGoogle ScholarPubMed
2. Shapiro, A. (1960). ‘A contribution to a history of the placebo effect.’ Behavioural Science, 5, 109–35.Google Scholar
3. British Medical Journal (1967). ‘Today's drugs: benzodiazepines.’ ii, 36–8.Google Scholar
4. British Medical Journal (1968). ‘Today's drugs; tranquillizers.’ ii, 230–1.Google Scholar
5. British Medical Journal (1968). ‘Today's drugs; treatment of psychoneurosis.’ ii, 288–9.Google Scholar
6. Lowinger, P., and Dobie, S. (1969). ‘What makes the placebo work?’ Archives of General Psychiatry, 20, 84–8.Google Scholar
7. Honigfled, G. (1964). ‘Non-specific factors in treatment; review of placebo reactions and placebo reactors.’ Diseases of the Nervous System, 25, 145–56.Google Scholar
8. Brodeur, D. W. (1965). ‘The effect of stimulant and tranquilizer placebos on healthy subjects in a real life situation.’ Psychopharmacologia, 7, 444–52.Google Scholar
9. Beecher, H. K. (1961). ‘Surgery as placebo.’ Journal of the American Medical Association, 176, 1102–7.Google ScholarPubMed
10. Shepherd, M., Lader, M., and Rodnight, R. (1968). Clinical Psychopharmacology. London: English Universities Press.Google Scholar
11. Vinar, O. (1969). ‘Dependence on a placebo: a case report.’ British Journal of Psychiatry, 115, 1189–90.Google Scholar
12. Schapira, K., McClelland, H. A., Griffiths, N. R., and Newell, D. J. (1970). ‘Study on the effects of tablet colour in the treatment of anxiety states.’ British Medical Journal, ii, 446–9.Google Scholar
13. Hamilton, M. (1959). ‘Assessment of anxiety states by rating.’ British Journal of Medical Psychology, 32, 50–5.CrossRefGoogle ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.